Article Sidebar
Views pdf: 93
CLINICAL AND PARACLINICAL CHARACTERISTICS AND OUTCOMES OF SURGICAL TREATMENT IN PATIENTS WITH TUBERCULOUS EMPYEMA AT CENTRAL LUNG HOSPITAL FROM 2019 TO 2021
Main Article Content
Abstract
Objective: The study aims to describe the clinical and paraclinical characteristics, as well as the surgical outcomes of video-assisted thoracoscopic surgery (VATS) for pleural decortication in patients with tuberculous empyema treated at the National Lung Hospital from 2019 to 2021. Methods: A cross-sectional, retrospective descriptive study was conducted on 81 patients diagnosed with stage II and III tuberculous empyema who underwent VATS. Data collected from medical records were processed and analyzed using SPSS statistical software, with a significance level of p < 0.05. Results: The average age of patients was 38.59 ± 15.51 years, with males accounting for 79.0%. The main clinical manifestations included chest pain (64.2%) and dyspnea (29.6%). Imaging studies revealed that 93.8% of patients had localized pleural effusion. Pleural fluid analysis typically showed purulent fluid with neutrophils exceeding 60%, and drug-resistant tuberculosis was detected in 14 cases (17.28%) from intraoperative samples. The average surgical duration was 159.51 minutes, with an average postoperative hospital stay of 11.04 ± 8.12 days. The postoperative complication rate was 23.45%, with prolonged air leak (17.3%) being the most common complication, and no mortality was recorded. The complication rate and postoperative hospital stay were significantly higher in stage III patients compared to stage II patients. 96.3% of patients showed significant improvement in radiographic findings and pulmonary function postoperatively. Conclusion: The study confirms the efficacy and safety of VATS in the treatment of tuberculous empyema. Early intervention with VATS contributes to rapid respiratory improvement, shorter hospital stays, and reduced postoperative complications. These results suggest that VATS can be considered a superior option in the clinical management of tuberculous empyema cases.
Article Details
Keywords
Empyema, tuberculous pleuritis, thoracoscopic surgery, VATS.
References
2. Đinh Văn Lượng. Nghiên cứu chẩn đoán và điều trị phẫu thuật viêm mủ màng phổi người lớn. Luận văn Tiến sĩ Y học, Trường Đại học Y Hà Nội, 2013.
3. Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017; 153(6):e129-e146.
4. Baofu Chen et al. Outcomes of Video-Assisted Thoracic Surgical Decortication in 274 Patients with Tuberculous Empyema. Ann Thorac Cardiovasc Surg. 2015;21(3):223-228.
5. Arvind Kumar et al. Thoracoscopic Decortication of Stage III Tuberculous Empyema Is Effective and Safe in Selected Cases. The Annals of Thoracic Surgery. 2017;104(5):1688-1694.
6. Đàm Hiếu Bình (2005), Nghiên cứu đặc điểm lâm sàng, cận lâm sàng ở bệnh nhân viêm mủ màng phổi có điều trị ngoại khoa, Đại học Y Hà Nội, Hà Nội.
7. Zhou Y, Li X, Dai J, et al. Uniportal Thoracoscopic Decortication for Stage III Tuberculous Empyema With Severe Rib Crowding. The Annals of Thoracic Surgery. 2021;112(1): 289-294.
8. Zeng X, Yue W, Ye S, Zhang L, Yang S. Evaluation of thoracic surgery as a treatment approach in patients with rifampin-resistant chronic tuberculous empyema. J Bras Pneumol. 48(4):e20220074.